Induction of antigen-specific Th1-biased immune responses by plasmid DNA in Schistosoma-infected mice with a preexistent dominant Th2 immune profile

被引:20
作者
Ayash-Rashkovsky, M
Weisman, Z
Zlotnikov, S
Raz, E
Bentwich, Z [1 ]
Borkow, G
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Kaplan Med Ctr, R Ben Ari Inst Clin Immunol, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Kaplan Med Ctr, AIDS Ctr, IL-76100 Rehovot, Israel
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA
关键词
DNA vaccines; Th1 and Th2 cytokine profile; beta-galactosidase; Schistosoma;
D O I
10.1006/bbrc.2001.4698
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A requisite for vaccines to confer protection against intracellular infections such as Human Immunadeficiency Virus or Mycobacterium tuberculosis is their capacity to induce Th1 immune responses. However, they may fail to do so in Africa and South East Asia, where most individuals have a dominant preexistent Th2 immune profile, due to persistent helminthic parasitic infections, which may undermine any Th1 response. It is well established that DNA vaccines induce strong Th1 biased immune responses against an encoded antigen, depending on the route and mode of immunization. Here, we demonstrate that intradermal immunization with plasmid DNA encoding p-gal (pCMV-LacZ) of Schistosoma-infected mice, with preexistent dominant Th2 immune background, induce a strong Th1 anti-beta -gal response, as opposed to immunized with beta -gal only. Importantly, the established protective Th2 immune response to schistosomes was not disrupted. These findings strongly support the possibility of using plasmid DNA as a Th1 inducing adjuvant when immunizing populations with a strong preexistent Th2 immune profile. (C) 2001 Academic Press.
引用
收藏
页码:1169 / 1176
页数:8
相关论文
共 47 条
[1]   HELMINTH INFECTION RESULTS IN DECREASED VIRUS-SPECIFIC CD8+ CYTOTOXIC T-CELL AND TH1-CYTOKINE RESPONSES AS WELL AS DELAYED VIRUS CLEARANCE [J].
ACTOR, JK ;
SHIRAI, M ;
KULLBERG, MC ;
BULLER, RML ;
SHER, A ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :948-952
[2]   Evidence of a T helper type 2 activation in human schistosomiasis [J].
Araujo, MI ;
deJesus, AR ;
Bacellar, O ;
Sabin, E ;
Pearce, E ;
Carvalho, EM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1399-1403
[3]  
Bentwich Z., 1997, Immunologist, V5, P21
[4]   Can eradication of helminthic infections change the face of AIDS and tuberculosis? [J].
Bentwich, Z ;
Kalinkovich, A ;
Weisman, Z ;
Borkow, G ;
Beyers, N ;
Beyers, AD .
IMMUNOLOGY TODAY, 1999, 20 (11) :485-487
[5]   Immune dysregulation in Ethiopian immigrants in Israel: Relevance to helminth infections? [J].
Bentwich, Z ;
Weisman, Z ;
Moroz, C ;
BarYehuda, S ;
Kalinkovich, A .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (02) :239-243
[6]   IMMUNE ACTIVATION IS A DOMINANT FACTOR IN THE PATHOGENESIS OF AFRICAN AIDS [J].
BENTWICH, Z ;
KALINKOVICH, A ;
WEISMAN, Z .
IMMUNOLOGY TODAY, 1995, 16 (04) :187-191
[7]  
Borkow G, 2000, B WORLD HEALTH ORGAN, V78, P1368
[8]   Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [J].
Borrow, P ;
Lewicki, H ;
Wei, XP ;
Horwitz, MS ;
Peffer, N ;
Meyers, H ;
Nelson, JA ;
Gairin, JE ;
Hahn, BH ;
Oldstone, MBA ;
Shaw, GM .
NATURE MEDICINE, 1997, 3 (02) :205-211
[9]  
Bundy DAP, 1998, BRIT MED BULL, V54, P421, DOI 10.1093/oxfordjournals.bmb.a011698
[10]   CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism [J].
Chiaramonte, MG ;
Hesse, M ;
Cheever, AW ;
Wynn, TA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :973-985